Texas House of Representatives Insurance Committee

The Committee on Insurance met for a public hearing to hear from invited testimony only on the following subjects: Examine and evaluate the effects of current regulations on the contractual relationships between pharmacists, pharmacies, health benefit plan issuers, and pharmacy benefit managers(PBMs).  Assess the effectiveness of existing laws in promoting transparency and fairness in drug pricing and out-of-pocket expenses for consumers. Study how PBM rebates function within the prescription drug market. Study programs which aim to increase transparency, improve quality of care for patients, and support public policy decisions. Analyze the effects of prohibiting certain contractual provisions that limit the ability of insurers to guide patients toward specific healthcare providers. Examine the impact of current economic challenges on the escalating cost of health insurance premiums and options available to Texans in the small business and individual health insurance marke